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MBoC | ARTICLE

The formin FMNL3 assembles plasma membrane
protrusions that participate in cell–cell adhesion
Timothy J. Gauvin, Lorna E. Young, and Henry N. Higgs
Department of Biochemistry, Geisel School of Medicine at Dartmouth, Hanover, NH 03755

ABSTRACT FMNL3 is a vertebrate-specific formin protein previously shown to play a role in
angiogenesis and cell migration. Here we define the cellular localization of endogenous
FMNL3, the dynamics of GFP-tagged FMNL3 during cell migration, and the effects of FMNL3
suppression in mammalian culture cells. The majority of FMNL3 localizes in a punctate pattern, with >95% of these puncta being indistinguishable from the plasma membrane by fluorescence microscopy. A small number of dynamic cytoplasmic FMNL3 patches also exist,
which enrich near cell–cell contact sites and fuse with the plasma membrane at these sites.
These cytoplasmic puncta appear to be part of larger membranes of endocytic origin. On the
plasma membrane, FMNL3 enriches particularly in filopodia and membrane ruffles and at
nascent cell–cell adhesions. FMNL3-containing filopodia occur both at the cell–substratum
interface and at cell–cell contacts, with the latter being 10-fold more stable. FMNL3 suppression by siRNA has two major effects: decrease in filopodia and compromised cell–cell adhesion in cells migrating as a sheet. Overall our results suggest that FMNL3 functions in assembly of actin-based protrusions that are specialized for cell–cell adhesion.
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INTRODUCTION
Formins are actin polymerization factors, and the large number of
mammalian formins (15 distinct genes) suggests a wide range of
cellular functions (Higgs and Peterson, 2005; Campellone and
Welch, 2010). However, precise cellular function is poorly understood for many mammalian formins, as opposed to our much better
understanding of formin function in budding or fission yeast
(Moseley and Goode, 2006; Kovar et al., 2011). Part of the challenge to elucidation of mammalian formin function is the diversity of
mammalian actin-based structures, which are often spatially and
structurally interrelated.
The FMNL subfamily of formins (also called FRL formins; Higgs
and Peterson, 2005) is metazoan specific, not being found in yeasts
or plants. Whereas Drosophila and Caenorhabditis elegans contain
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one FMNL, vertebrates contain three genes: FMNL1, FMNL2, and
FMNL3. Each vertebrate FMNL possesses at least two splice variants. As with other formins, FMNLs are modular (Vaillant et al., 2008;
Heimsath and Higgs, 2012), with the following functional regions
(Figure 1): GTPase-binding domain (GBD), diaphanous inhibitory
domain (DID), dimerization domain (DD), formin homology 1 domain (FH1), formin homology 2 domain (FH2), WH2-like domain
(WH2L), and diaphanous autoregulatory domain (DAD). The FH2
domain binds actin- filament barbed ends and can accelerate filament nucleation, as well as regulate filament elongation. In FMNLs,
the FH2 has poor actin nucleation activity but can bundle filaments
in vitro (Vaillant et al., 2008; Harris et al., 2004, 2010; Block et al.,
2012). C-terminal to the FH2 domain, FMNLs contain a WH2-like
actin monomer–binding sequence, which is capable of capping
barbed ends in isolation or accelerating actin nucleation when coupled to the FH2 domain (Heimsath and Higgs, 2012). Similar to
other formins, FMNL regulation is through autoinhibitory interaction
of the DID and DAD regions, with activation by Rho GTPase binding
to the GBD (Seth et al., 2006; Block et al., 2012). Finally, FMNLs are
known or suspected to be N-terminally myristoylated (Han et al.,
2009; Block et al., 2012; Moriya et al., 2012), which is a modification
not found in other formins.
The cellular functions of FMNLs are incompletely understood.
FMNL1 (also called FRL1) has been implicated in diverse functions,
including cell migration, phagocytosis, myofibril development, podosome assembly, and centrosome polarization (Seth et al., 2006;
467

background (see later discussion of Figure
7D and Supplemental Figure S6B). We focus
on the peripheral, siRNA-sensitive stained
regions.
FMNL3 mostly appears as punctate staining, with puncta diameters close to the limit
of resolution (370 ± 50 nm, n = 82; Figure
2D). In cells plated on glass overnight, these
puncta are present throughout the cell but
enrich at areas of apparent membrane protrusion (Figure 2A and Supplemental Figure
S1A). This enrichment is observed most easFIGURE 1: FMNL3 domain map and splice variants. DAD, diaphanous autoregulatory domain.
ily when cells are induced to spread upon
DID, diaphanous inhibitory domain; DD, dimerization domain; FH1, formin homology 1 domain;
FH2, formin homology 2 domain; GBD, GTPase-binding domain; WH2L, WH2-like domain.
replating. U2OS cells spread asymmetrically
Numbers indicate amino acid positions. Splice variants: DID insert (153–203) and alternate
on laminin, allowing clear observation of the
C-termini (NC and PH variants, named by the two C-terminal residues). Red letters represent the FMNL3-rich spreading edge as opposed to
last common sequence before the alternative splice site. DAD is predicted to extend into the
the FMNL3-poor nonspreading edge (Figure
alternately spliced region (with L1000 predicted to make an important interaction with DID).
2B). In addition, short filopodia are visible at
the spreading edges of U2OS cells on lamiGomez et al., 2007; Mersich et al., 2010; Favaro et al., 2013; Naj et al.,
nin, and FMNL3 is enriched at filopodial tips in these cells (Figure 2B,
2013; Rosado et al., 2014). One FMNL1 splice variant localizes at or
inset). 3T3 cells plated on poly-l-lysine (PLL) spread uniformly, and
near the Golgi and plays a role in Golgi structure and function (ColonFMNL3 enriches significantly at the spreading edge, still in a puncFranco et al., 2011). FMNL2 (also called FRL3) plays a role in cell mitate pattern (Supplemental Figure S1B).
gration (Block et al., 2012) and appears to be particularly important in
We also examined FMNL3 localization in a wound-healing conmetastasis of certain cancers (Zhu et al., 2008, 2011; Kitzing et al.,
text in which cells are plated on glass at high density overnight and
2010; Li et al., 2010; Liang et al., 2013). In mouse melanoma cells,
then scrape-wounded and allowed to migrate into the wound for
FMNL2 localizes to the leading-edge plasma membrane, where it apseveral hours. Again, FMNL3 enriches at the leading edge during
pears to promote lamellipodial extension by allowing elongation of
wound closure (Figure 2C and Supplemental Figure S1C), but
Arp2/3 complex–nucleated filaments (Block et al., 2012).
filopodia are not apparent upon fixation in either 3T3 or U2OS cells
The cellular functions of FMNL3 (also called FRL2) are less de(however, see later discussion of evidence that fixation ablates these
fined than those of FMNL1 or FMNL2. FMNL3 plays a role in angiofilopodia, Figure 8). FMNL3 also enriches at some but not all areas
genesis in zebrafish (Hetheridge et al., 2012). In PC3 prostate cancer
of cell–cell contact (Figure 2C and Supplemental Figure S1C). From
cells, which migrate as single cells, FMNL3 depletion inhibits cell
these results, we conclude that FMNL3 localizes largely to diffracmigration (Bai et al., 2011; Vega et al., 2011). However, there is little
tion-limited puncta throughout the cell, with particular enrichment
information on what types of actin-based structure are promoted by
at areas of active cell protrusion or cell–cell contacts.
FMNL3 (filopodia, lamellipodia, etc) and no information as to
We further investigated FMNL3 enrichment to actively protruding
FMNL3’s localization. A previous study in our laboratory showed
regions of the plasma membrane using serum readdition after serum
that overexpression of minimal FMNL3 constructs (containing FH1
starvation of NIH 3T3 cells. The most intense FMNL3 enrichment is to
and FH2 domains) potently induced filopodia, whereas a similar
areas of cell–cell contact, with clear enrichment within 10 min (Figure
construct of FMNL1 did not (Harris et al., 2010), but this result does
3). N-cadherin, the predominant cadherin in 3T3 cells, enriches at
not speak to the function of the endogenous protein.
contact sites on a similar time scale (Figure 3). At early time points
In this work, we examine the location, dynamics, and function of
after serum readdition, the FMNL3/N-cadherin enrichment resemFMNL3 in adherent culture cells (U2OS and 3T3). We show that the
bles interdigitating filopodia, similar to observations made in other
majority of FMNL3 localizes in a punctate pattern at the plasma
systems (Adams et al., 1998; Vasioukhin et al., 2000; Brevier et al.,
membrane, with particular enrichment at filopodia, ruffles, and cell–
2008; Hoelzle and Svitkina, 2012). Later in the process, the contact
cell adhesions. A small pool of intracellular FMNL3 is present as
site becomes compact, and the filopodia are no longer evident.
dynamic puncta that enrich near cell–cell adhesion sites and are associated with larger internal membrane structures. FMNL3 suppresLive-cell analysis of FMNL3 localization and dynamics
sion decreases both filopodial number and stability at the leading
The preceding experiments were conducted using immunofluoresedge, as well as the integrity of cell–cell contacts.
cence detection of endogenous FMNL3. To analyze FMNL3 dynamics, we developed a green fluorescent protein (GFP)–fusion protein. It
RESULTS
is worth mentioning that several challenges presented themselves
FMNL3 localizes in a punctate pattern that enriches at the
during this development. First, there are two known alternatively
leading edge and cell–cell contacts
spliced sites for FMNL3: a variably present 51–amino acid insert in the
As a first step in determining FMNL3 function, we examined localizaDID, and alternate C-termini of 30 or 29 amino acids (Figure 1). We
tion of the endogenous protein in U2OS human osteosarcoma cells
determined that U2OS cells expressed the variant containing the DID
(Figure 2) and NIH 3T3 mouse fibroblasts (Supplemental Figure S1) by
insert and the NC C-terminus (Supplemental Figure S2) and used this
immunofluorescence microscopy, using an affinity-purified antibody
variant (called “NC”) henceforth. Second, we found that placing the
against the FH2 domain. The specificity of this antibody for FMNL3 is
GFP at either the N- or C-terminus caused localization patterns that
indicated by the effect of small interfering RNA (siRNA) suppression,
were clearly different from that of endogenous FMNL3, with GFPwhich removes all of the peripheral immunofluorescence staining,
FMNL3 localization being entirely internal and FMNL3-GFP being
leaving a hazy perinuclear staining that we interpret as nonspecific
entirely on the plasma membrane and causing a significant increase
468 | T. J. Gauvin et al.
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FIGURE 2: Localization of FMNL3 in U2OS cells. U2OS cells were examined in three conditions: (A) plated on glass
coverslips overnight, (B) plated on laminin coated slips for 120 min, and (C) during wound-healing assay, 23 h after
wounding. Stains are anti-FMNL3 antibody (green), phalloidin for actin filaments (red), and DAPI for DNA (blue). Right,
zooms. Arrow in B indicates a filopodium, and arrow in C indicates region of cell–cell contact, which runs diagonally
from this arrow to the lower right corner. Scale bars,10 μm (full images), 5 μm (zooms). (D) Histogram of FMNL3 puncta
diameters from images of fixed U2OS cells stained with anti-FMNL3 antibodies. Bins are 50 nm, bars are centered at the
maximum value of that bin (e.g., bar centered on 350 nm represents 300–350 nm). Similar to images for NIH 3T3 cells
shown in Supplemental Figure S1.

in filopodia (Supplemental Figure S3). For this reason, we developed
a construct in which the GFP was placed at the N-terminal end of the
FH1 domain (construct called the FMNL3-NC-GFPint), which is a region predicted to adopt a nonfolded structure (Paul and Pollard,
2009; Courtemanche and Pollard, 2012). FMNL3-NC-GFPint produces a pattern more similar to endogenous FMNL3 in fixed cells,
both at leading edge and puncta (Supplemental Figure S3). Third, we
were unable to generate stable cell lines constitutively expressing
FMNL3-NC-GFPint from a cytomegalovirus promoter. For this reason,
we developed a stable doxycycline-inducible FMNL3-NC-GFPint line
in U2OS cells, which displays low-level expression after 18–24 h of
induction. Quantification of GFP-FMNL3 and total FMNL3 levels suggests that FMNL3-NC-GFPint levels are significantly less than endogenous FMNL3 levels in all cells examined (Supplemental Figure S4).
Volume 26 February 1, 2015

Using this cell line, we first examined localization of FMNL3
puncta in more detail. Our initial laser-scanning confocal microscopy
analysis of fixed cells stained for endogenous FMNL3 suggested that
FMNL3 puncta were predominately at/near the plasma membrane
(PM; Figure 4A), but the flattening that occurred upon cell fixation/
permeabilization rendered interpretation of these data challenging.
Similar three-dimensional (3D) reconstructions of live U2OS cells expressing FMNL3-NC-GFPint provide a much less ambiguous result.
As a marker for both the plasma membrane and internal membranes,
we used fluorescent wheat germ agglutinin (WGA), which binds Nacetyl-glucosamine and sialic acid moieties on the cell surface and
gets rapidly endocytosed (Raub et al., 1990). Immediately after WGA
treatment, the vast majority of FMNL3 puncta reside at positions indistinguishable from the PM (Figure 4B and Supplemental Movies S1
FMNL3 cellular dynamics
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FIGURE 3: FMNL3 translocates to nascent cell–cell junctions upon serum addition. Serum-starved NIH 3T3 cells were
treated with serum-containing medium (10% newborn calf serum) for the indicated times and then fixed and stained for
FMNL3 (green), N-cadherin (red), and DNA (blue). Scale bar, 10 μm (close-ups, 5 μm ).

and S2), with <5% of the puncta being clearly separate from the PM
(three cells counted, 14/280, 17/476, and 17/586 internal puncta/
total puncta, respectively). As opposed to the spherical structures
observed by fixed-cell immunofluorescence, the surface FMNL3
staining observed in 3D reconstruction images of FMNL3-NC-GFPint
is more oblate and somewhat interconnected.
The cytoplasmic FMNL3 puncta are rapidly motile in the vicinity
of the FMNL3-enriched cell–cell contact, with some undergoing
random movement and others moving directionally (Figure 5, A and
B, and Supplemental Movie S3). Occasionally, the puncta move to
and fuse with the plasma membrane (Supplemental Movie S2). We
observe no LifeAct enrichment around these puncta (unpublished
data), suggesting that their dynamics is actin-independent. When
cells are treated with WGA for longer times to label endocytic compartments, subpopulations of cytoplasmic FMNL3 and WGA structures colocalize in an intriguing manner. The cytoplasmic FMNL3
puncta appear as diffraction-limited spheres that are clearly associated with the larger WGA-labeled structures (Figure 5, C and D).
Both the FMNL3 and associated WGA structures can move rapidly
in the cytoplasm (Figure 5D and Supplemental Movie S4).
Next we examined the dynamics of FMNL3-NC-GFPint at the
cell surface. On the basal surface, FMNL3 puncta are relatively static,
showing little change in movement over several minutes (Figure
6A). The apical puncta are difficult to track because of the rapid
changes in the surface in general. Near protrusive regions, however,
FMNL3 displays an association with membrane ruffles that are also
enriched in actin, as detected by LifeAct (Figure 6B and Supplemental Movie S5) or mCherry-actin (Supplemental Figure S5). These
ruffles are highly dynamic but do not move consistently in a retrograde manner (Figure 6C and Supplemental Movie S5). The ruffles
also stain brightly with WGA, and the dynamics of the WGA stain
overlaps the dynamics of FMNL3 in the ruffles (Figure 6, B and C).
Treatment with latrunculin B causes dissipation of both FMNL3 and
actin signals within 2 min (Supplemental Figure S5).
FIGURE 4: Localization of FMNL3 puncta. (A) XZ-projection of fixed
U2OS cells immunostained for endogenous FMNL3 (green), plasma
membrane (red), and DNA (blue), then imaged by laser scanning
confocal microscopy using 100-nm Z-slices. Plasma membrane labeled
with FM4-64 (50 μM in Hank’s buffered salt solution) for 1 min before
fixation. XZ-projection reconstructed using Nikon Elements software
with 2× scale of Z-axis. Scale bar, 10 μm (XY), 5 μm (Z). (B) A 3D
470 | T. J. Gauvin et al.

reconstruction of FMNL3-NC-GFPint (green) and Alexa 647–labeled
WGA (red) in live U2OS cell at <1 min after WGA treatment (top) and
at 5 min after treatment (bottom). The Z-stack was deconvolved
before assembling the 3D image. Scale bar, 2 μm (XY), 1 μm (Z). See
corresponding Supplemental Movies S1 and S2.
Molecular Biology of the Cell

FIGURE 5: Dynamics of cytoplasmic FMNL3 puncta near cell–cell contact sites. (A) Individual time points from
Supplemental Movie S2, following cytoplasmic FMNL3-NC-GFPint puncta near the cell–cell contact. Note the circled
punctum, which has recently undergone fission from the larger punctum and fuses with the plasma membrane (arrow).
Scale bar, 5 μm. See corresponding Supplemental Movie S3. (B) Trajectory plots for individual intracellular puncta, with
the origin representing the starting position for each punctum. Units are in pixels, 0.151 μm/pixel. (C) Single time frame
(14 min) from live-cell recording, showing FMNL3-NC-GFPint (green) and Alexa 647–WGA (red) after >10 min of WGA
treatment, which allows time for endocytic uptake of WGA. Individual FMNL3 (left) and WGA (center) are also shown
in black and white. Box indicates approximate region shown in D and Supplemental Movie S4. Scale bar, 5 μm.
(D) Montage taken from Supplemental Movie S4, showing FMNL3-NC-GFPint (green) and WGA (red) dynamics over
50-s period (individual frames represent 10-s intervals). Two WGA-containing particles are labeled. Particle 1 is relatively
static over this time period, whereas particle 2 moves rapidly, becoming dimmer but still distinguishable during the
process. See also Supplemental Movie S4 from 14:10 to 15:00. Scale bar, 2 μm.

FMNL3 also enriches in filopodia, both at protrusive edges and
at cell–cell contacts (Figure 6D). The stability of filopodia at these
two locations differs greatly, with protrusive-edge filopodia having
much shorter lifetimes (median 2.5 ± 1.7 min) than cell-cell–contact
filopodia (median 25 ± 6.5 min), with many contact filopodia being
stable throughout the 27-min viewing period (Figure 6, D and E, and
Supplemental Movies S6 and S7). The cell–cell contact protrusions
appear to be bona fide filopodia and not retraction fibers because
the majority exhibits clear growth during observation time and are
not under any apparent tension (Supplemental Movie S7). We note
that the FMNL3 features observed here (surface puncta, cytoplasmic puncta, ruffles, and filopodia) are not dependent on WGA treatment (unpublished data).

FMNL3 suppression results in loss of leading-edge filopodia
and unstable cell–cell contacts
We used siRNA-mediated suppression to examine the importance
of FMNL3 to cellular dynamics, focusing on U2OS cells due to the
Volume 26 February 1, 2015

ability to attain >85% suppression levels (Figure 7, A and B). FMNL3
suppression also reduces by >80% the number of puncta observed
using the anti-FMNL3 antibody (Figure 7, C and D), suggesting that
these puncta do indeed correspond to FMNL3. A similar reduction
in anti-FMNL3–stained puncta occurs upon FMNL3 suppression in
3T3 cells (Supplemental Figure S6).
FMNL3 suppression does not have a strong effect on spreading
rate for U2OS on laminin or 3T3 cells on PLL (unpublished data), nor
does FMNL3 suppression affect wound closure rate in the woundhealing assay (Supplemental Figure S7, A and B). However, FMNL3
suppression does compromise filopodial abundance during both
spreading and wound healing. In U2OS cells spreading on laminin,
filopodial density decreases by >50% upon FMNL3 suppression
(Figure 7, E and F). In live-cell analysis of wound healing, we detect
abundant and highly dynamic filopodia at the leading edges of control wound-edge cells, with lifetimes of 116 ± 56 s (Figure 8A and
Supplemental Movie S8). FMNL3 suppression causes a 3.4-fold
reduction in filopodial number and a significant decrease in the
FMNL3 cellular dynamics
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FIGURE 6: Dynamics of FMNL3 in basal puncta, membrane ruffles, and filopodia. All images use U2OS cells expressing
FMNL3-NC-GFPint. (A) Three frames of a time-lapse movie examining FMNL3 on the basal surface, with the overlay of
the three frames on the right. In the overlay, note the preponderance of white puncta, indicating that they did not
displace significantly over the 4-min viewing time. Scale bar, 5 μm. (B) 3D reconstructions of protrusive regions, with
FMNL3 in green and either LifeAct (left) or WGA (right) in red. Ruffles protrude above the apical cell surface.
(C) Individual frames from time-lapse movies, tracking FMNL3 and either LifeAct (top) or WGA (bottom). Scale bar, 5 μm.
Corresponds to Supplemental Movie S5 (LifeAct). (D) Individual frames from time-lapse movies following FMNL3 in
filopodia at a free cell edge (“edge,” top) or a cell edge that is in contact with another cell (“contact,” bottom). In the
latter case, the cell being contacted is not expressing FMNL3 (and is invisible here but visible by DIC microscopy). Scale
bar, 5 μm. Corresponds to Supplemental Movies S6 and S7. (E) Filopodia lifetimes for contact and edge filopodia,
measured from five cells. A substantial proportion of contact filopodia were present for the entire recorded time (27 min).

lifetimes of the remaining filopodia (70.6 ± 37 s; Figure 8, A–C, and
Supplemental Movie S9). The presence of leading-edge filopodia in
our live-cell imaging of wound healing contrasts with our finding of
few filopodia in fixed cells under the same conditions (Figure 2C),
suggesting that formaldehyde fixation destroys these transient
structures.
Because FMNL3 enriches at cell–cell contacts, we analyzed the
effects of FMNL3 suppression on the stability of cell–cell contacts
during wound healing. Control U2OS cells migrate as a sheet, with
few gaps between cells (Figure 9A). In fixed-cell assays, the area of
these gaps increases >2.5-fold upon FMNL3 suppression (Figure
9B). In live-cell imaging, control cells maintain tight contact, and any
small gaps close rapidly (Figure 9C and Supplemental Movie S10).
In contrast, FMNL3-suppressed cells display frequent gaps between
cells, and these gaps close approximately threefold more slowly
(Figure 9, C and D, and Supplemental Movie S11). Gaps appear to
result from the reduced ability of neighboring cells to maintain stable interaction upon contact, suggesting that FMNL3 suppression
results in decreased cell–cell adhesion.
472 | T. J. Gauvin et al.

DISCUSSION
In this article, we show that FMNL3 localizes in a punctate pattern
in U2OS and 3T3 cells, with >95% of these puncta being at or near
the plasma membrane. Further enrichment occurs in several
places: at the leading-edge plasma membrane, particularly at
filopodial tips; at the ridges of apical membrane ruffles; and at
cell–cell contact sites. The relatively infrequent cytoplasmic
FMNL3 puncta are dynamic and can fuse with the plasma membrane at cell–cell contact sites. Suppression of FMNL3 by siRNA
causes a reduction in filopodia at the leading edge and in cell–cell
adhesion for U2OS cells migrating as a sheet in wound-healing
assays.
The identity of the abundant FMNL3 puncta found at the cell
surface is intriguing. From 3D reconstructions of cells expressing the
GFP-FMNL3 construct, we find 300–600 surface puncta, all at or
near the diffraction limit. At the level of light microscopy, we cannot
determine whether these puncta represent vesicles that are closely
associated with the plasma membrane (akin to secretory vesicles)
or are actually regions of FMNL3 enrichment on the plasma
Molecular Biology of the Cell

FIGURE 7: Effects of FMNL3 suppression in U2OS cells. (A) Western blot showing suppression of FMNL3 using two
different siRNAs. (B) Percentage suppression, determined by density measurements from Western blots.
(C) Quantification of average puncta per 10 μm2 area in control and FMNL3-depleted cells. Error bars represent SD.
(D) Cells plated on laminin-coated coverslips for 90 min for control (top) and siRNA1 treatment (bottom). Stains were for
FMNL3 (green), actin filaments (red), and DNA (blue). Scale bar, 10 μm. (E) Close-ups of spreading edge in control (left)
siRNA knockdown (right column) shows decrease of filopodia present along the edge compared with control (left
column). Filopodia indicated with arrows. Scale bar, 5 μm. (F) Graph quantifying filopodia density as filopodia per 10-μm
length along the spreading edge. Error bars indicate SD; p < 0.001.

membrane, representing lateral segregation (“domains”). Either
possibility is intriguing functionally.
The relatively sparse cytoplasmic FMNL3 puncta display interesting features. First, they enrich near cell–cell contact sites, as
opposed to a noncontacting region of the cell. Second, they are
dynamic and can translocate to the cell–cell contact site, where
they fuse with the plasma membrane. Third, the puncta are associated with larger membrane structures derived from endocytosis. These features suggest that the cytoplasmic puncta might
Volume 26 February 1, 2015

be components of dynamic internal membranes that are delivering components to the contact site. There is ample evidence for
recycling of adhesion components at cell–cell contact sites (Le
et al., 1999; Akhtar and Hotchin, 2001; Palacios et al., 2005;
Desclozeaux et al., 2008; Peglion et al., 2014), and FMNL3 could
be either part of this recycling system or one of the components
that is recycled. The discrete enrichment of FMNL3 puncta to
specific regions of these internal membranes is intriguing
and could suggest confinement on associated small vesicles or
FMNL3 cellular dynamics
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FIGURE 8: FMNL3 suppression reduces filopodial number and lifetime at leading edge of U2OS cells in wound-healing
assays. (A) Time-lapse montage of DIC images of leading edge of cells in control and knockdown cells. Arrows indicate
filopodia. Scale bar, 10 μm. Corresponds to Supplemental Movies S8 and S9. (B) Quantification of average filopodium
lifetime. Error bars indicate SD. (C) Quantification of filopodia assembly frequency. Error bars indicate SD.

possibly membrane segregation on the endosomal membrane
(Trajkovic et al., 2008).
The finding that FMNL3 enriches in filopodia, as well as the effect
of FMNL3 suppression on filopodial abundance, extends our previous observation that minimal constructs of FMNL3 (containing the
FH1 and FH2 domains) are capable of filopodial induction (Harris et al.,
2010). Our work here shows that filopodial assembly is a bona fide
function of FMNL3, as opposed to a potentially artifactual effect of
the FH1-FH2 construct. FMNL3-assembled filopodia might be specialized for cell–cell adhesion, based on two observations: the filopodia are 10-fold more stable when in contact with another cell, and
FMNL3 suppression causes defects in cell–cell adhesion. Filopodia
clearly play a role in cadherin-mediated cell–cell adhesion in both
epithelial (Adams et al., 1998; Vasioukhin et al., 2000; Brevier et al.,
2008) and endothelial cells (Hoelzle and Svitkina, 2012), and our
work here shows that N-cadherin enriches with FMNL3 at cell–cell
contacts. It will be interesting to determine whether FMNL3-induced
filopodia preferentially enrich cell–cell adhesion molecules.
The difficulty experienced in producing a GFP-tagged FMNL3
construct that suitably mimics endogenous FMNL3 localization
might be an indication of peculiarities in FMNL3 regulation. N-terminally tagged FMNL3 did not localize to the plasma membrane
but instead to intracellular aggregates, which might not be surprising, given the N-terminal myristoylation site that was ablated by the
tag (Han et al., 2009; Block et al., 2012; Moriya et al., 2012). Of
474 | T. J. Gauvin et al.

greater interest, C-terminally tagged FMNL3 appeared “constitutively active,” localizing intensely to the plasma membrane and
causing a significant increase in filopodia. This result suggests that
the extreme C-terminus influences FMNL3 regulation and might relate to previous findings showing FMNL3 to be less tightly regulated
than FMNL2 (Vaillant et al., 2008) and mDia2 (Harris et al., 2010).
It is interesting that our study finds no defect in cell migration
upon FMNL3 suppression, whereas a previous study did identify a
migration defect (Bai et al., 2011). A major difference in the two
studies is the cell lines used. In our study, we used U2OS and 3T3
cells, both of which display strong cell–cell adhesion and migrate
as a sheet in wound-healing assays. The previous study used PC3
human prostate cancer cells, which display weak cell–cell adhesion
and migrate as single cells in wound-healing assays. One possibility is that FMNL3’s role is cell-type dependent, participating predominantly in cell–cell adhesion in adhesive cell lines and participating more in cell migration in less adhesive cells. In any case, it
is clear that FMNL3, like the other vertebrate FMNLs, has several
cellular roles, so the elucidation of these roles is likely to produce
new surprises in the future.

MATERIALS AND METHODS
Cell lines and culture conditions
U2OS (human osteosarcoma, originally from Duane Compton,
Dartmouth, Hanover, NH) and NIH 3T3 cells (originally from
Molecular Biology of the Cell

FIGURE 9: FMNL3 suppression increases intercellular gaps between U2OS cells in wound- healing assays. (A) Phasecontrast (top) and merged fluorescence images (bottom) of FMNL3 (green), actin (red), and DNA (blue) along wound
edge of control (left) and siRNA1-treated cells (right) show an increase of intercellular gaps (marked by asterisks) upon
FMNL3 depletion. Scale bars, 10 μm. Corresponds to Supplemental Movies S10 and S11. (B) Graph shows average
areas of intercellular spaces. Error bars show SEM; p < 0.005. (C) DIC time-lapse montage of wound edge in control and
knockdown cells. Arrows indicate intercellular gaps forming during time lapse. Scale bar indicates 10 μm. (D) Average
lifetime of intercellular gaps during wound healing. Error bars indicate SD.

Gregg Gundersen, Columbia University, New York) were cultured in
DMEM (Corning, Corning, NY) and 10% newborn calf serum
(Altanta Biologicals, Flowery Branch, GA) at 37°C and 5% CO2. For
U2OS cell lines transfected with the pTet-on Advance plasmid
(Clontech, Mountain View, CA) and U2OS Tet-on FMNL3-NCGFPint construct, the serum used was 10% Tet-approved fetal
bovine serum (Clontech). To induce expression of FMNL3-NC
GFPint, cells were incubated in 1 μg/ml doxycycline (Fisher Scientific,
Pittsburgh, PA) for 18–24 h before imaging.

Plasmids and siRNA constructs
All FMNL3 constructs were created from a human FMNL3 open
reading frame (ORF) containing the DID insert and the PH C-terminal splice variant (Figure 1), a kind gift from John Copeland
(University of Ottawa, Canada). To generate the NC variant, the
NC C-terminus was amplified by 23°C PCR from U2OS cell cDNA,
Volume 26 February 1, 2015

using primers containing Kpn1 and EcoR1 sites, and ligated with
the rest of the FMNL3 ORF into the pcDNA3.1 vector (Invitrogen,
Waltham, MA). All enhanced GFP constructs used were the A206K
mutant (low dimerization affinity; Zacharias et al., 2002). The
FMNL3-GFP and GFP-FMNL3 constructs were in the pEGFP-N1
and pEGFP-C1 vectors, respectively (Clontech). The FMNL3-NCGFPint construct was made in the pcDNA3.1 vector by digesting
with Bsu36i and inserting an amplified GFP construct containing
a flexible GSG linker and Bsu36i sites on both ends. The GFP
construct is inserted at amino acids 512–513 in the FMNL3 sequence (Supplemental Figure S4). The FMNL3-NC GFPint was
moved from pcDNA3.1 to pTRE-tight (Clontech) for Tet-on system using EcoR1/NotI restriction sites. FMNL3-GFP was cloned in
the pGFP-N1 vector with BamH1 sites, and the GFP-FMNL3 construct was cloned into GFP-C1 vector using BamH1 sites. siRNA
constructs were purchased from Life Technologies (Carlsbad, CA)
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(siRNA1, CAUUCGUUCUUACAAGGAA; siRNA 2, GCAUCAAGG
AGACAUAUGA). Scrambled siRNA was purchased from Integrated DNA Technologies (Negative Control #1).
For production of the stable FMNL3-NC-GFPint cell line, U2OS
stably expressing pTet-on Advance (gift from Bernardo Orr
[Dartmouth] and Duane Compton) were transfected with FMNL3NC GFPint in the pTRE-tight vector (Clontech) using jetPrime
(Polypus Transfection). Cells were selected using 0.2 mg/ml G418 in
growth medium. Cells were then selected using 0.1 mg/ml hygromycin (Clontech) for 2 wk (to reselect for the pTRE-tight vector) before picking colonies. After selection, colonies were picked, and cells
expressing FMNL3-NC-GFPint were screened by anti-FMNL3 Western blotting after inducing each colony with 1 μg/ml doxycycline for
24 h. Pilot experiments showed undetectable expression in the absence of doxycycline (Supplemental Figure S4) and that expression
levels were relatively constant from 18 to 30 h postinduction.

Antibodies and other labeling reagents
The anti-FMNL3 antibody was raised in guinea pig (Covance) using
the FMNL3-FH1FH2 construct (Harris et al., 2010) as antigen and
affinity-purified using this same antigen coupled to sulfolink resin
(Thermo Scientific, Waltham, MA). Anti–N-cadherin (mouse, #C3845)
and anti-tubulin (mouse, DM1alpha) antibodies were purchased from
Sigma-Aldrich (St. Louis, MO). Alexa 488 and Alexa 546–labeled
anti–guinea pig secondary antibody and FM4-64 were purchased
from Life Technologies. Texas Red–labeled anti-mouse was obtained
from Vector Laboratories. Tetramethylrhodamine isothiocyanate
(TRITC)–labeled phalloidin was purchased from Sigma-Aldrich. Alexa
647–WGA (Life Technologies) was a kind gift from Brent Berwin
(Geisel School of Medicine at Dartmouth).

Cell treatments, fixation, and staining for
immunofluorescence
For the spreading assay, 12-mm coverslips were coated overnight
with either 0.01% PLL (Sigma-Aldrich) or 20 μg/μl laminin (SigmaAldrich). A confluent plate of cells was trypsinized and diluted in
phosphate-buffered saline (PBS) before two washes in PBS. Cells
were resuspended to 100,000 cells/ml in prewarmed medium before
plating 0.5 ml onto coated coverslips. Cells were incubated at 37°C
until ready to fix. For serum readdition, NIH 3T3 cells were serum
starved by rinsing twice with PBS and incubating in DMEM for at least
20 h. Medium was changed to normal growth medium (10% newborn calf serum) for indicated times before fixation. After treatment,
cells were washed once with room temperature PBS, then immediately fixed with 4% paraformaldehyde (Electron Microscopy Sciences,
Hatfield, PA) diluted in room temperature PBS for 20 min. Cells were
washed and permeabilized with 0.20% Triton X-100 for 20 min at
room temperature. Cells were blocked using 10% newborn calf serum diluted in PBS for 1 h at room temperature. Cells were incubated
with primary antibodies (FMNL3 1:600, N-cadherin 1:200) diluted in
PBS with 1% newborn calf serum for 1 h. Cells were washed, and
secondary antibodies diluted 1:500 in PBS were added for 1 h.
TRITC–phalloidin was used at 50 nM. Cells were stained with 0.4 ng/μl
4′,6-diamidino-2-phenylindole (DAPI) for 10 min before final rinse
with PBS. Cells were mounted to glass slides using PVA-DABCO. Images were acquired using a Nikon TE-2000E microscope with either
the 60×/1.4 numerical aperture (NA) or 4×/0.13 NA objective, a
Roper CoolSnap camera, and Nikon Elements software.

Wound-healing assays
Cells were plated at high density (310,000 cells on 18-mm coverslips in a 12-well plate) and incubated overnight. Coverslips were
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assessed for formation of a complete monolayer before making
scratches. Scratches were made by attaching a p10 tip to a vacuum
manifold set at half strength; a straight line was drawn down
the center of the coverslip by holding the tip perpendicular to the
coverslip. Wound width was measured at three different spots
along the wound from images taken with the 4× objective. For live
imaging, cells were incubated for 2 h after making scratches before imaging.

Live-cell microscopy
Coverslips were mounted into modified Rose chambers and then
onto a Wave FX spinning disk confocal microscope (Quorum
Technologies [Guelph, Canada], on a Nikon Eclipse microscope)
with Bionomic Controller (20/20 Technology) temperature-controlled stage set to 37°C. After equilibrating to temperature for
5 min, cells were imaged through the 60×/1.4 NA Plan Apo objective (Nikon USA, Melville, NY) using the 491-nm laser and 525/20
filter for GFP and the 561-nm laser and 593/40 filter for monomeric red fluorescent protein and 655/90 for far red and differential interference contrast (DIC). Z-stacks of 0.2 μm were collected
for each color at 10- to 30-s intervals. Maximum intensity projections from five Z-slices were assembled using Nikon Elements
software. For 3D reconstructions of Z-stacks of fixed cells, images
were deconvolved using Huygens software and reassembled using Nikon Elements. Alexa 647–labeled WGA was resuspended in
dimethyl sulfoxide (DMSO) at a concentration of 1 mg/ml, diluted
to 500 ng/ml in medium, and added to cells, which were imaged
within 1 min to capture the plasma membrane. To observe endocytic compartments, cells were imaged 5–10 min after WGA treatment (endocytic structures were visible within 3 min of treatment).
FM4-64 was resuspended fresh from a 50-μg vial in DMSO. The
dye was then diluted to 50 μM Hank’s balanced salt solution and
added to cells on ice for 1 min before fixation.

Quantification
Intercellular area was defined as the total area between two cells
along their lateral contact (perpendicular to the wound direction)
at the edge or first interior layer of a wounded monolayer. The
lateral contact length varied between 30 and 60 μm for both control and FMNL3-suppressed cells. Filopodia frequency was calculated from the number of filopodia that appeared in 25 min along
a 50-μm length of protrusive cell edge, and filopodia lifetime was
determined from frame-by-frame analysis of the movie files. For
filopodia at cell–cell contacts, many lasted the length of the movie
(∼25 min) and thus were given that lifetime. Puncta diameter was
measured using Nikon Elements software from 100×/1.4 NA images of fixed cells stained with anti-FMNL3. Because the puncta
appeared circular by eye, the diameter was measured horizontally
across each punctum. From this analysis, the mean punctual diameter is 370 ± 50 nm (n = 82), with no observed punctum being
>540 in nm diameter. To quantify the expression level of FMNL3NC-GFPint, we examined fixed cells by immunofluorescence microscopy, staining induced and uninduced cells with anti-FMNL3
and Alexa 546–labeled secondary antibody. Anti-FMNL3 recognizes both endogenous FMNL3 and FMNL3-NC-GFPint. We quantified total GFP and Alexa 546 fluorescence for each cell (normalizing both to cell area, and background subtracting from areas of
the coverslip devoid of cells) and plotted total FMNL3 fluorescence (Alexa 546) as a function of GFP fluorescence. The resulting
graph is shown in Supplemental Figure S4 and indicates that even
the cells with highest FMNL3-NC-GFPint induction had no more
than twofold increase in total FMNL3. The cells selected for
Molecular Biology of the Cell

observation expressed significantly less GFP than the highest-expressing cells. Therefore, we conclude that the levels of FMNL3NC-GFPint in our live-cell experiments were less than the level of
endogenous FMNL3.
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